Racial disparities permeate every part of the US criminal justice system, including in the enforcement of drug laws. Black people make up 13 percent of the population and 13 percent of all adults who use drugs, but 27 percent of all drug arrests. Black men are incarcerated at nearly six times the rate of white men.
Police continue to kill black people in numbers disproportionate to their overall share of the population. Black people are 2.5 times as likely as white to be killed by police. An unarmed black person is five times as likely to be killed by police as an unarmed white person.
The Trump administration has expressed almost unconditional support for the prerogatives of law enforcement officers, scaling back or altogether removing police oversight mechanisms. The US Department of Justice began to discontinue investigations into, and monitoring of, local police departments reported to have patterns and practices of excessive force and constitutional violations.
The administration reversed an order from the Obama administration limiting acquisition of offensive military weaponry by local police departments. In a speech in July, President Trump encouraged officers to use unnecessary force on suspects. Congress introduced the “Back the Blue Act,” which would severely restrict civilians’ rights to sue police officers who unlawfully injure them.
Despite voicing concern over the opioid crisis, the Trump administration signaled an intent to re-escalate the “war on drugs” and de-emphasize bipartisan public health approaches to drug policy. Attorney General Jeff Sessions rescinded his predecessor’s Smart on Crime initiative, which had prioritized federal prosecutions of individuals accused of high-level drug offenses, reduced racial disparities in federal drug sentencing, and improved re-entry opportunities.